Pamela Metten
Affiliations: | Oregon Health and Science University, Portland, OR | ||
| Portland VA Medical Center, United States |
Area:
behavioral pharmacogenetics, drug abuseGoogle:
"Pamela Metten"Mean distance: 17.33 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| John C. Crabbe | grad student | 1989-1996 | PVAMC / OHSU | |
| (to current as Lab Mgr/CoI) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Grigsby KB, Mangieri RA, Roberts AJ, et al. (2023) Pre-clinical and clinical evidence for suppression of alcohol intake by apremilast. The Journal of Clinical Investigation |
| Zhou Z, Metten P, Yuan Q, et al. (2022) Genetic and genomic signatures in ethanol withdrawal seizure-prone and seizure-resistant mice implicate genes involved in epilepsy and neuronal excitability. Molecular Psychiatry |
| Savarese AM, Metten P, Phillips TJ, et al. (2022) Midazolam, methamphetamine, morphine and nicotine intake in high-drinking-in-the-dark mice. Addiction Biology. 27: e13212 |
| Crabbe JC, Hack WR, Ozburn AR, et al. (2021) Long-term alcohol drinking in High Drinking in the Dark mice is stable for many months and does not show alcohol deprivation effects. Addiction Biology. e13074 |
| Jensen BE, Townsley KG, Grigsby KB, et al. (2021) Ethanol-Related Behaviors in Mouse Lines Selectively Bred for Drinking to Intoxication. Brain Sciences. 11 |
| Savarese AM, Ozburn AR, Barkley-Levenson AM, et al. (2021) The impact of Drinking in the Dark (DID) procedural manipulations on ethanol intake in High Drinking in the Dark (HDID) mice. Alcohol (Fayetteville, N.Y.) |
| Crabbe JC, Ozburn AR, Hitzemann RJ, et al. (2020) Tetracycline derivatives reduce binge alcohol consumption in High Drinking in the Dark mice. Brain, Behavior, & Immunity - Health. 4: 100061 |
| Grigsby KB, Savarese AM, Metten P, et al. (2020) Effects of Tacrolimus and Other Immune Targeting Compounds on Binge-Like Ethanol Drinking in High Drinking in the Dark Mice. Neuroscience Insights. 15: 2633105520975412 |
| Savarese AM, Ozburn AR, Metten P, et al. (2020) Targeting the glucocorticoid receptor reduces binge-like drinking in High Drinking in the Dark (HDID-1) mice. Alcoholism, Clinical and Experimental Research |
| Crabbe JC, Ozburn AR, Hitzemann RJ, et al. (2020) Tetracycline derivatives reduce binge alcohol consumption in High Drinking in the Dark mice Brain, Behavior, & Immunity - Health. 4: 100061 |